# History and Physical

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Lorraine Hansberry (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML034-SYN-TD
- Date: 1963-04-20
- Fictional facility: St. Posthumous Health Center
- Fictional author: Odette Marchetti-Fields, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## Reason for visit

Two months of epigastric and back pain, weight loss, black stools and near-fainting in a woman of 32: examination, blood tests, and urgent upper endoscopy and pancreas-protocol CT. **S**

## Historical basis

- Lorraine Vivian Hansberry was born in Chicago on May 19, 1930, the youngest of four children of Carl Augustus Hansberry, a successful real estate broker who founded one of the city's first Black banks, and Nannie Louise (Perry) Hansberry, a schoolteacher. Her grandfather had been born enslaved. **D**
- In 1937 her family moved into a house in the all-white Washington Park subdivision of Woodlawn in defiance of a racially restrictive covenant. The resulting case, Hansberry v. Lee, was decided in the family's favor by the U.S. Supreme Court in 1940. **D**
- Her father died suddenly in Mexico in 1946 of a cerebral hemorrhage while planning to move the family there. **D**
- She enrolled at the University of Wisconsin in 1948, left in 1950 for New York, and wrote for the newspaper Freedom. In June 1953 she married Robert Nemiroff. Sources differ on when they divorced (1962 or 1964); they continued to work together. **D**
- A Raisin in the Sun opened at the Ethel Barrymore Theatre on Broadway on March 11, 1959, the first play by a Black woman to be produced on Broadway. It won the New York Drama Critics' Circle Award; she was the first Black playwright and, at 29, the youngest American to win it. In 1962 she moved to Croton-on-Hudson, New York. **D**
- One account dates the start of her illness to April 1963, when she began to suffer from fainting spells and attacks of nausea; tests pointed at first to what was suspected to be a duodenal ulcer. **D**

5 later historical claims are omitted because they describe events after the index age. See the teaching note.

These claims are historical evidence, not findings from a real modern examination.

## History of present illness

This fictional modern episode addresses the presenting concerns below. **S**

- Burning, boring pain under the breastbone and through to the back for about two months, worse after meals and at night; black stools on and off for three weeks; two near-fainting spells; weight down 5 kg. **S**
- An urgent care clinic put the pain down to indigestion and stress five weeks ago; she does not want it put down to stress again, and wants the cause found and told to her plainly, whatever it is. **S**
- She wants to finish her play and to keep writing through whatever treatment she needs, with a clear head. **S**

## Strengths and supports

- Engagement in care and meaningful activity **S**

## Medications and allergies

- Pantoprazole 40 mg delayed-release oral tablet, one tablet by mouth once daily before breakfast **S**
- No known allergy **S**

## Past medical history

True biography with historical dates; these events are not part of the synthetic care timeline.

- No historical medical events recorded.

## Procedures and immunizations

- No procedures before this visit. **S**
- 1959-09-12: Tdap vaccine **S**

## Family history

- father: Died suddenly of a cerebral hemorrhage when she was sixteen; no cancer recorded in the cited source **D** (CLM-0003)

## Measurements

Hemoglobin: 9.1 g/dL (low); MCV: 74 fL (low); White cell count: 7.4 10*3/uL; Platelets: 388 10*3/uL; Ferritin: 6 ng/mL (low); Sodium: 138 mmol/L; Potassium: 4 mmol/L; Creatinine: 0.7 mg/dL; eGFR (CKD-EPI 1958): 118 mL/min/1.73 m²; Glucose: 132 mg/dL (high); ALT: 48 U/L (high); AST: 41 U/L (high); Alkaline phosphatase: 236 U/L (high); Total bilirubin: 1.6 mg/dL (high); Albumin: 3.6 g/dL; Lipase: 52 U/L; Hemoglobin A1c: 6.6% (high); PHQ-2: 1; Pain score (0 to 10): 5. All results are synthetic.

BP 104/66 mmHg; pulse 102 bpm; respirations 16/min; temperature 36.8 °C; oxygen saturation 99% on room air; weight 56.2 kg; BMI 21.2 kg/m². All vital signs are synthetic.

## Examination

Mental status: Alert, articulate and exact; worried and tired; PHQ-2 negative; no thoughts of self-harm. Functional status: Independent; working full days until the last two weeks, when tiredness and pain cut her writing to the mornings (ECOG performance status 1). Physical examination is intentionally limited. **S**

## Assessment

1. Epigastric pain for about two months, boring through to the back and worse after meals and lying flat, with nausea, early fullness, a loss of 5 kg (8 percent of her weight), and pale, loose stools: an upper abdominal cause such as a bleeding ulcer or a pancreatic or duodenal tumor must be found. Upper endoscopy and pancreas-protocol CT booked this week; status draft. **S**
2. Iron deficiency anemia from chronic upper gastrointestinal blood loss: black stools on and off for three weeks, two near-fainting spells, hemoglobin 9.1 g/dL, MCV 74 fL, ferritin 6 ng/mL; status draft. **S**
3. New hyperglycemia: A1c 6.6% and random glucose 132 mg/dL in a lean woman of 32 who is losing weight; new diabetes with weight loss can be the first sign of a pancreatic cancer, so it is to be confirmed and explained, not labeled type 2; status draft. **S**

## Plan

- Medical oncology consultation within two weeks to review the endoscopy, CT and any biopsy with her and plan treatment if cancer is found. Guideline: NCCN Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma (2026); Khorana AA, et al. Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 2016;34(21):2541-2556 (PMID 27247221) (2016) **S**
- Urgent work-up of epigastric pain with weight loss, anemia and new diabetes: upper endoscopy within days, pancreas-protocol CT of the abdomen with CT of the chest, blood count, ferritin, liver tests, lipase and A1c; pantoprazole until the endoscopy; return at once for fresh black stools, fainting or yellow eyes. Guideline: NCCN Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma (2026); Noel M, Fiscella K. Disparities in Pancreatic Cancer Treatment and Outcomes. Health Equity 2019;3(1):532-540 (PMID 31663065) (2019) **S**
- Intravenous iron for iron deficiency anemia from blood loss, with a blood count at each visit. Guideline: NCCN Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma (2026) **S**
- Distress and depression screening at each visit, plain explanations with written information, and support she chooses; she decides who is told and who receives each note. Guideline: Sanders JJ, et al. Palliative Care for Patients With Cancer: ASCO Guideline Update. J Clin Oncol 2024;42(19):2336-2357 (PMID 38748941) (2024); Depression and Suicide Risk in Adults: Screening (2023) **S**

## Guideline basis

- NCCN Clinical Practice Guidelines in Oncology: Pancreatic Adenocarcinoma (2026), National Comprehensive Cancer Network
- Khorana AA, et al. Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 2016;34(21):2541-2556 (PMID 27247221) (2016), American Society of Clinical Oncology
- Sanders JJ, et al. Palliative Care for Patients With Cancer: ASCO Guideline Update. J Clin Oncol 2024;42(19):2336-2357 (PMID 38748941) (2024), American Society of Clinical Oncology
- Noel M, Fiscella K. Disparities in Pancreatic Cancer Treatment and Outcomes. Health Equity 2019;3(1):532-540 (PMID 31663065) (2019), Health Equity (Mary Ann Liebert)
- Dhali A, et al. Racial Disparities in Pancreatic Cancer: A Comprehensive Population-Based Analysis of Survival, Surgical Access, and Prognostic Factors. Am J Clin Oncol 2026 (PMID 41996299) (2026), American Journal of Clinical Oncology
- Depression and Suicide Risk in Adults: Screening (2023), U.S. Preventive Services Task Force
